Concepedia

Wenli Wan

WW

Statistics

Publications

6

Citations

142

H-Index

6

Active since

1994

Affiliations

Peking University Third Hospital(Current)

Peking University

Wenli Wan is an author at Peking University Third Hospital specializing in molecular oncology, chemotherapy in hematologic malignancies, and immunology.

Publications per year

1994–2022

6

Publications

6

B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells

Wei Zhang, Jing Wang, Yanfang Wang et al. · OncoTargets and Therapy · 2015 · 49 citations · Full text

, , +11

B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity

Wei Zhang, Yanfang Wang, Jing Wang et al. · International Journal of Oncology · 2015 · 30 citations · Full text

, , +14

Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.

Steve Zalcman, Julia M. Green-Johnson, Lesley Murray et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 23 citations

, , +17

Expression and role of MIG/CXCR3 axis in mantle cell lymphoma

Mingxia Zhu, Wenli Wan, Yun Hong et al. · Experimental Cell Research · 2020 · 17 citations

, , +12

Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells in vitro

Mingxia Zhu, Wenli Wan, Hai-Shen Li et al. · Experimental Cell Research · 2015 · 13 citations

, , +14

1–5 of 6